You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLINICAL TRIALS PROFILE FOR VANCERIL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for VANCERIL

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00489203 ↗	Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer	Completed	Fred Hutchinson Cancer Research Center	Phase 2	2007-04-01	RATIONALE: Beclomethasone dipropionate may be effective in preventing acute graft-versus-host disease in patients undergoing a stem cell transplant for hematologic cancer. PURPOSE: This randomized phase II trial is studying how well beclomethasone dipropionate works in preventing acute graft-versus-host disease in patients undergoing a donor stem cell transplant for hematologic cancer.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for VANCERIL

Condition Name

Chart
Table

Condition Name for VANCERIL
Intervention	Trials
Recurrent Adult T-cell Leukemia/Lymphoma	1
Stage I Small Lymphocytic Lymphoma	1
Essential Thrombocythemia	1
Stage IV Adult T-cell Leukemia/Lymphoma	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for VANCERIL
Intervention	Trials
Leukemia, Myeloid, Acute	1
Sezary Syndrome	1
Blast Crisis	1
Lymphomatoid Granulomatosis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for VANCERIL

Trials by Country

Map
Table

Trials by Country for VANCERIL
Location	Trials
United States	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for VANCERIL
Location	Trials
Washington	1
New Jersey	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for VANCERIL

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for VANCERIL
Clinical Trial Phase	Trials
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for VANCERIL
Clinical Trial Phase	Trials
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VANCERIL

Sponsor Name

Chart
Table

Sponsor Name for VANCERIL
Sponsor	Trials
Fred Hutchinson Cancer Research Center	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for VANCERIL
Sponsor	Trials
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.